US-backed hepatitis B vaccine trial in Guinea-Bissau halted
A planned hepatitis B vaccine trial in newborns will not proceed in Guinea-Bissau after failing to secure government approval, its lead researcher said.
AI-written summary · The Chestnut Post · · How we use AI
A US-backed hepatitis B vaccine trial involving newborns in Guinea-Bissau has been halted after drawing international criticism, its lead researcher said Wednesday.
Danish researcher Frederik Schaltz-Buchholzer wrote on LinkedIn that the study would not proceed in the country because the necessary government approval had not been granted.
The trial was due to receive funding from the US Centers for Disease Control and Prevention, according to The Guardian.
Originally reported by The Guardian. Read the full story at The Guardian
